Bottom line
IQLT vs BBIN: the short answer
IQLT (iShares MSCI Intl Quality Factor ETF) and BBIN (JPMorgan BetaBuilders International Equity ETF) share a meaningful slice of their top holdings — about 57% by weight.
But BBIN is far broader, holding 643 positions to 320 for IQLT, so beyond the top names it adds exposure IQLT doesn't have.
BBIN is cheaper at 0.07% vs 0.3% — a difference of $23 a year per $10,000 invested.
Over five years, BBIN returned +9.1% a year vs +5.5% for IQLT (reporting dates differ).
Updated Nov 19, 2026
IQLT vs BBIN side by side
| IQLT | BBIN | |
|---|---|---|
| Type | ETF | ETF |
| Fund family | iShares | J.P. Morgan |
| Category | International Stock | International Stock |
| Expense ratio | 0.3% | 0.07% |
| Annual cost per $10k | $30 | $7 |
| 10-yr cost on $10k (prospectus) | $381 | $90 |
| Max front load | None | None |
| 12b-1 fee | 0% | — |
| 1-yr return | +1.7% | +32.1% |
| 5-yr return (annualized) | +5.5% | +9.1% |
| 10-yr return (annualized) | +6.4% | — |
| Best quarter | +17.8% | +18.3% |
| Worst quarter | −19.5% | −23.1% |
| Net assets (fund) | $13.8B | $6.6B |
| Number of holdings | 320 | 643 |
| Portfolio turnover | 2% | 5% |
| Returns as of | Dec 31, 2024 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | IQLT | BBIN | Difference |
|---|---|---|---|
| 2024 | +1.7% | +3.5% | −1.8% |
| 2023 | +18.5% | +18.2% | +0.3% |
| 2022 | −15.1% | −14.1% | −1.0% |
| 2021 | +12.8% | +11.4% | +1.4% |
| 2020 | +13.1% | +8.6% | +4.5% |
Source: Fund prospectus bar charts
Holdings overlap
12 of IQLT's top 25 holdings also appear in BBIN's top 25.
| Holding | IQLT | BBIN |
|---|---|---|
| ASML Holding N.V. | 5.42% | 2.93% |
| Allianz SE | 2.68% | 0.87% |
| Roche Holding AG | 2.20% | 1.38% |
| ABB Ltd | 1.95% | 0.70% |
| Nestle S.A. | 1.81% | 1.14% |
| Novartis AG | 1.78% | 1.37% |
| Astrazeneca Plc | 1.68% | 1.21% |
| Shell Plc | 1.59% | 1.17% |
| Rolls-royce Holdings Plc | 1.50% | 0.76% |
| Schneider Electric Se | 1.43% | 0.83% |
| Totalenergies Se | 1.32% | 0.85% |
| Novo Nordisk A/s | 1.12% | 0.69% |
Source: SEC Form N-PORT
IQLT top 10
- ASML Holding N.V. — 5.42%
- Allianz SE — 2.68%
- Roche Holding AG — 2.20%
- ABB Ltd — 1.95%
- Zurich Insurance Group AG — 1.83%
- Nestle S.A. — 1.81%
- Novartis AG — 1.78%
- Astrazeneca Plc — 1.68%
- Advantest Corporation — 1.65%
- Shell Plc — 1.59%
BBIN top 10
- ASML Holding NV — 2.93%
- HSBC Holdings plc — 1.68%
- Roche Holding AG — 1.38%
- Novartis AG — 1.37%
- AstraZeneca plc — 1.21%
- Shell plc — 1.17%
- Mitsubishi UFJ Financial Group, Inc. — 1.16%
- Nestle SA — 1.14%
- Siemens AG — 1.07%
- Toyota Motor Corp. — 0.99%
FAQ
What is the difference between IQLT and BBIN?
Which is cheaper, IQLT or BBIN?
Should I own both IQLT and BBIN?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.